Quick Answer
Teladoc Health, Inc. reported Research And Development Expense of $277.92 million for the year ending 2025.
- Teladoc Health, Inc. showed a decrease of -9.6% in Research And Development Expense from 2024 to 2025.
- This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $2.06 million | Q3 2014: $1.96 million | Q1 2015: $2.91 million | Q2 2015: $3.20 million | Q3 2015: $3.94 million | Q1 2016: $5.23 million | Q2 2016: $4.83 million | Q3 2016: $5.87 million | Q4 2016: $5.89 million | Q1 2017: $6.51 million | Q2 2017: $7.54 million | Q3 2017: $9.96 million | Q4 2017: $10.45 million | Q1 2018: $12.90 million | Q2 2018: $14.35 million | Q3 2018: $13.58 million | Q4 2018: $13.54 million | Q1 2019: $15.99 million | Q2 2019: $16.67 million | Q3 2019: $15.75 million | Q4 2019: $16.25 million | Q1 2020: $19.26 million | Q2 2020: $23.03 million | Q3 2020: $29.96 million | Q1 2021: $78.01 million | Q2 2021: $80.76 million | Q3 2021: $80.25 million | Q1 2022: $87.41 million | Q2 2022: $78.70 million | Q3 2022: $84.59 million | Q1 2023: $86.99 million | Q2 2023: $87.31 million | Q3 2023: $84.29 million | Q1 2024: $81.39 million | Q2 2024: $76.75 million | Q3 2024: $72.38 million | Q1 2025: $69.96 million | Q2 2025: $68.78 million | Q3 2025: $67.57 million.
- Over the full 13 years of available data (2013 to 2025), Teladoc Health, Inc.'s Research And Development Expense has grown by 7,768.7%.
- Historical annual values: Fiscal year 2025: $277.92 million | Fiscal year 2024: $307.27 million | Fiscal year 2023: $348.52 million | Fiscal year 2022: $333.63 million | Fiscal year 2021: $311.88 million | Fiscal year 2020: $164.94 million | Fiscal year 2019: $64.64 million | Fiscal year 2018: $54.37 million | Fiscal year 2017: $34.46 million | Fiscal year 2016: $21.82 million | Fiscal year 2015: $14.21 million | Fiscal year 2014: $7.57 million | Fiscal year 2013: $3.53 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: